TransMedics (TMDX) Share-based Compensation Growth (1y) (2019 - 2026)
TransMedics (TMDX) Share-based Compensation Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn | 11.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.10% |
| Sep 30, 2025 | 749.70% |
| Jun 30, 2025 | 893.07% |
| Mar 31, 2025 | 30.39% |
| Sep 30, 2024 | 53.12% |
| Jun 30, 2024 | 54.15% |
| Mar 31, 2024 | 75.21% |
| Dec 31, 2023 | -497.73% |
| Sep 30, 2023 | 91.86% |
| Jun 30, 2023 | 114.08% |
| Mar 31, 2023 | 69.74% |
| Dec 31, 2022 | 50.68% |
| Sep 30, 2022 | 37.05% |
| Jun 30, 2022 | 28.10% |
| Mar 31, 2022 | 107.73% |
| Dec 31, 2021 | 184.38% |
| Sep 30, 2021 | 181.86% |
| Jun 30, 2021 | 186.53% |
| Mar 31, 2021 | 188.83% |
| Dec 31, 2020 | 147.52% |